Thomas Snelling

Featured in: Favicon

thelancet.com Favicon

paediatricsandchildhealthjournal.co.uk Favicon

onlinelibrary.wiley.com Favicon

Articles

Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): Statistica

Dec 1, 2024 | medrxiv.org | Mark Jones |James Totterdell |Parveen Fathima |Thomas Snelling

The authors have declared no competing interest. ACTRN12623000024640https://doi.org/10.1186/s13063-024-08212-8Motivate-C is funded via a 2020 Medical Research Future Fund (MRFF) under the PPHR Initiative (Efficient of existing medicines) - (Ref: 2007164). Tom Snelling is additionally supported by a MRFF Investigator Award (MRF1195153). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific

Oct 30, 2023 | thelancet.com | Phoebe C.M. Williams |Mark Jones |Thomas Snelling |Robert C Duguid

SummaryHigh levels of antimicrobial resistance (AMR) are propagating deaths due to neonatal and paediatric infections globally. This is of particular concern in Southeast Asia and the Pacific, where healthcare resources are constrained and access to newer agents to treat multidrug-resistant pathogens is limited.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →